CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Calypso Knee System (Implantable Shock Absorber)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03838978
NCT03838978N/ACompleted

Evaluation of the Calypso Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis, OUS

Moximed·interventional·Posted Feb 12, 2019·Updated Apr 10, 2025

In Brief

A clinical study evaluating Calypso Knee System (Implantable Shock Absorber) for Osteoarthritis, Knee. Completed, enrolled 81 participants across 5 sites in 2 countries.

Detailed Summary

A study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, Poland
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 12, 2019
Enrollment StartFeb 8, 2019
Primary CompletionJan 17, 2022
Study CompletionMar 14, 2025
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 7.4 years ago

Interventions

Calypso Knee System (Implantable Shock Absorber)device

The Calypso Knee System is an extra-capsular knee implant designed to fill the therapeutic gap between conservative care and more invasive surgical interventions for knee osteoarthritis.